These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 16978272

  • 1. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, Lane JA, Peters TJ.
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [Abstract] [Full Text] [Related]

  • 2. Psychological distress and prostate specific antigen levels in men with and without prostate cancer.
    Turner EL, Lane JA, Metcalfe C, Down L, Donovan JL, Hamdy F, Neal D, Vedhara K.
    Brain Behav Immun; 2009 Nov; 23(8):1073-8. PubMed ID: 19486654
    [Abstract] [Full Text] [Related]

  • 3. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.
    Carlsson S, Aus G, Wessman C, Hugosson J.
    Eur J Cancer; 2007 Sep; 43(14):2109-16. PubMed ID: 17643983
    [Abstract] [Full Text] [Related]

  • 4. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
    Macefield RC, Lane JA, Metcalfe C, Down L, Neal DE, Hamdy FC, Donovan JL.
    Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
    [Abstract] [Full Text] [Related]

  • 5. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
    Pinnock CB, Weller DP, Marshall VR.
    Med J Aust; 1998 Jul 06; 169(1):25-8. PubMed ID: 9695698
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S, Charoenkraikamol C, Toraksa S, Uiprasertkul M, Amornvesukit T, Taweemonkongsap T, Udompunturak S, Nualyong C, Tantiwong A.
    J Med Assoc Thai; 2006 Jan 06; 89(1):37-42. PubMed ID: 16583579
    [Abstract] [Full Text] [Related]

  • 7. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
    Cohen L, Fouladi RT, Babaian RJ, Bhadkamkar VA, Parker PA, Taylor CC, Smith MA, Gritz ER, Basen-Engquist K.
    Cancer Epidemiol Biomarkers Prev; 2003 Jul 06; 12(7):610-7. PubMed ID: 12869399
    [Abstract] [Full Text] [Related]

  • 8. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ, Volk RJ, Cass AR, Spann SJ.
    J Fam Pract; 1999 Sep 06; 48(9):682-8. PubMed ID: 10498074
    [Abstract] [Full Text] [Related]

  • 9. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.
    Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W.
    Cancer; 2003 Jun 01; 97(11):2910-8. PubMed ID: 12767107
    [Abstract] [Full Text] [Related]

  • 10. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
    van den Bergh RC, Essink-Bot ML, Roobol MJ, Schröder FH, Bangma CH, Steyerberg EW.
    J Urol; 2010 May 01; 183(5):1786-91. PubMed ID: 20299064
    [Abstract] [Full Text] [Related]

  • 11. Do "rapid" PSA assays reduce anxiety and stress of prostate cancer patients undergoing regular review? A prospective evaluation.
    Wilkinson S, Warren K, Ramsden A, Matthews A, Chodak G.
    Urology; 2008 Apr 01; 71(4):567-72. PubMed ID: 18387384
    [Abstract] [Full Text] [Related]

  • 12. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J.
    Patient Educ Couns; 2006 Nov 01; 63(3):367-79. PubMed ID: 16875796
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
    Dyche DJ, Ness J, West M, Allareddy V, Konety BR.
    J Urol; 2006 Jun 01; 175(6):2078-82. PubMed ID: 16697807
    [Abstract] [Full Text] [Related]

  • 14. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J, Tretarre B, Grosclaude P, Rebillard X, Bataille V, Malavaud B, Iborra F, Salama G, Rischmann P, Villers A.
    Prog Urol; 2009 Jul 01; 19(7):487-98. PubMed ID: 19559380
    [Abstract] [Full Text] [Related]

  • 15. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS, Goel V, Williams JI, Iscoe NA.
    CMAJ; 1999 Jan 12; 160(1):70-5. PubMed ID: 9934349
    [Abstract] [Full Text] [Related]

  • 16. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
    Beemsterboer PM, de Koning HJ, Kranse R, Trienekens PH, van der Maas PJ, Schröder FH.
    J Urol; 2000 Oct 12; 164(4):1216-20. PubMed ID: 10992369
    [Abstract] [Full Text] [Related]

  • 17. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.
    Mokete M, Shackley DC, Betts CD, O'Flynn KJ, Clarke NW.
    BJU Int; 2006 Feb 12; 97(2):266-9. PubMed ID: 16430626
    [Abstract] [Full Text] [Related]

  • 18. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR.
    Int J Urol; 2007 May 12; 14(5):406-11. PubMed ID: 17511722
    [Abstract] [Full Text] [Related]

  • 19. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I, Weiss NS, Lin DW, Stanford JL.
    Cancer Causes Control; 2007 Nov 12; 18(9):931-7. PubMed ID: 17641982
    [Abstract] [Full Text] [Related]

  • 20. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less.
    Ito K, Yamamoto T, Ohi M, Takechi H, Kurokawa K, Suzuki K, Yamanaka H.
    Prostate; 2003 Sep 15; 57(1):8-13. PubMed ID: 12886518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.